ClinicalTrials.gov
public full text
Public Domain
A Study of LY2584702 in Participants With Advanced Cancer
The main purpose of this trial is to determine a recommended Phase 2 dose of LY2584702 that may be safely administered to participants with advanced/metastatic cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY2228820 in Participants With Advanced Cancer#836269
- LY293111 in Treating Patients With Advanced Solid Tumors#857662
- Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer#1087459
- A Study of LY3463251 in Healthy Participants#906560
- A Study of LY3007113 in Participants With Advanced Cancer#855258
Record · ID 911461
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive